Camptothecin-20(S)-O-propionate
|
C646911-50mg
|
≥99% |
194414-69-2 |
50mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
Camptothecin-20(S)-O-propionate
|
C646911-10mg
|
≥99% |
194414-69-2 |
10mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
Camptothecin-20(S)-O-propionate
|
C646911-100mg
|
≥99% |
194414-69-2 |
100mg
|
¥ 25500.9
|
期货,请咨询 |
阿拉丁 |
Cevidoplenib dimesylate
|
C646901-5mg
|
≥98% |
2043659-93-2 |
5mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
Cevidoplenib dimesylate
|
C646901-50mg
|
≥98% |
2043659-93-2 |
50mg
|
¥ 18000.9
|
期货,请咨询 |
阿拉丁 |
Cevidoplenib dimesylate
|
C646901-25mg
|
≥98% |
2043659-93-2 |
25mg
|
¥ 11500.9
|
期货,请咨询 |
阿拉丁 |
Cevidoplenib dimesylate
|
C646901-10mg
|
≥98% |
2043659-93-2 |
10mg
|
¥ 6000.9
|
期货,请咨询 |
阿拉丁 |
Crinecerfont hydrochloride
|
C646900-5mg
|
≥98% |
321839-75-2 |
5mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
Crinecerfont hydrochloride
|
C646900-10mg
|
≥98% |
321839-75-2 |
10mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
Cot inhibitor-1
|
C646885-5mg
|
≥98% |
915365-57-0 |
5mg
|
¥ 2300.9
|
期货,请咨询 |
阿拉丁 |
Cot inhibitor-1
|
C646885-50mg
|
≥98% |
915365-57-0 |
50mg
|
¥ 13500.9
|
期货,请咨询 |
阿拉丁 |
Cot inhibitor-1
|
C646885-2mg
|
≥98% |
915365-57-0 |
2mg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
Cot inhibitor-1
|
C646885-25mg
|
≥98% |
915365-57-0 |
25mg
|
¥ 7600.9
|
期货,请咨询 |
阿拉丁 |
Cot inhibitor-1
|
C646885-10mg
|
≥98% |
915365-57-0 |
10mg
|
¥ 3700.9
|
期货,请咨询 |
阿拉丁 |
Cot inhibitor-1
|
C646885-100mg
|
≥98% |
915365-57-0 |
100mg
|
¥ 22000.9
|
期货,请咨询 |
阿拉丁 |
Cynaropicrin
|
C646868-5mg
|
|
35730-78-0 |
5mg
|
¥ 1180.9
|
期货,请咨询 |
阿拉丁 |
Cynaropicrin
|
C646868-1mg
|
|
35730-78-0 |
1mg
|
¥ 480.9
|
期货,请咨询 |
阿拉丁 |
Cynaropicrin
|
C646868-10mg
|
|
35730-78-0 |
10mg
|
¥ 1900.9
|
期货,请咨询 |
阿拉丁 |
Calenduloside E
|
C646832-5mg
|
≥98% |
26020-14-4 |
5mg
|
¥ 4030.9
|
期货,请咨询 |
阿拉丁 |
Calenduloside E
|
C646832-10mg
|
≥98% |
26020-14-4 |
10mg
|
¥ 6860.9
|
期货,请咨询 |
阿拉丁 |
C26 D,L-Carnitine-d9
|
C646812-1mg
|
≥99% |
2260670-67-3 |
1mg
|
¥ 26000.9
|
期货,请咨询 |
阿拉丁 |
CCR8 antagonist 1
|
C646764-5mg
|
≥98% |
723304-76-5 |
5mg
|
¥ 2600.9
|
期货,请咨询 |
阿拉丁 |
CCR8 antagonist 1
|
C646764-50mg
|
≥98% |
723304-76-5 |
50mg
|
¥ 12800.9
|
期货,请咨询 |
阿拉丁 |
CCR8 antagonist 1
|
C646764-25mg
|
≥98% |
723304-76-5 |
25mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |